| AD | Alzheimer’s Disease |
| AMPAR | α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor |
| Aβ | amyloid β |
| Aβo | amyloid β oligomers |
| CaM | calmodulin |
| CJD | Creutzfeldt–Jakob disease |
| CSF | Cerebrospinal Fluid |
| CT | computer tomography |
| CTRL | controls |
| ELISA | enzyme-linked immunosorbent assay |
| GAP-43 | Growth Associated Protein 43 |
| GluA4 | glutamate ionotropic receptor AMPA type subunit 4 |
| LTD | long-term depression |
| LTP | long-term potentiation |
| MCI | Mild cognitive impairment |
| MRI | magnetic resonance image |
| NDD | neurochemical dementia biomarkers |
| Ng | Neurogranin |
| NMDAR | N-methyl-D-aspartate receptor |
| NPTXR | Neuronal pentraxin receptor |
| PET | Positron Emission Tomography |
| pTau181 | phosphorylation Tau protein (Threonine 181) |
| SNAP-25 | Synaptosomal-Associated Protein 25 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.